Willmann, S., Marostica, E., Snelder, N., Solms, A., Jensen, M., Lobmeyer, M., . . . Bhanot, S. (2021). PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients. Wiley.
Style de citation Chicago (17e éd.)Willmann, Stefan, et al. PK/PD Modeling of FXI Antisense Oligonucleotides to Bridge the Dose‐FXI Activity Relation from Healthy Volunteers to End‐stage Renal Disease Patients. Wiley, 2021.
Style de citation MLA (8e éd.)Willmann, Stefan, et al. PK/PD Modeling of FXI Antisense Oligonucleotides to Bridge the Dose‐FXI Activity Relation from Healthy Volunteers to End‐stage Renal Disease Patients. Wiley, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.